Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology

April 22, 2014 8:22 am | News | Comments

Elite's abuse deterrent products utilize the company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist.

TOPICS:

E-cig Industry Awaits Looming FDA Regulation

April 22, 2014 8:14 am | by MICHAEL FELBERBAUM, AP Tobacco Writer | News | Comments

Smokers are increasingly turning to battery-powered electronic cigarettes to get their nicotine fix. They're about to find out what federal regulators have to say about the popular devices. The Food and Drug Administration will propose rules for e-cigarettes as early as this month.

TOPICS:

FDA Accepts Gilead's NDAs for Cobicistat and Elvitegravir for HIV Therapy

April 22, 2014 8:09 am | News | Comments

Gilead Sciences announced that the FDA has accepted the company’s refiling of two New Drug Applications (NDA) for cobicistat, a pharmacoenhancing or “boosting” agent that increases blood levels of the protease inhibitors atazanavir and darunavir to enable once-daily dosing of these medicines in HIV therapy, and elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults.

TOPICS:
Advertisement

FDA Approves Cyramza for Stomach Cancer

April 22, 2014 8:05 am | News | Comments

The FDA has approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.       

TOPICS:

Novartis, GSK, Lilly in Multibillion-Dollar Deals

April 22, 2014 4:28 am | by John Heilprin - Associated Press - Associated Press | News | Comments

Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.

TOPICS:

Allergan Draws Bid from Valeant

April 22, 2014 12:29 am | by Ken Sweet - AP Business Writers - Associated Press | News | Comments

Valeant said Monday that it intends to propose a merger with Allergan using a combination of Valeant stock and cash. The transaction size has not been disclosed, but Valeant expects the cash portion of the deal to be at least $15 billion.   

TOPICS:

Saudi Health Minister Sacked Amid Virus Deaths

April 21, 2014 1:49 pm | by ABDULLAH AL-SHIHRI, Associated Press | News | Comments

Saudi Arabia's King Abdullah sacked the country's health minister on Monday amid a spike in deaths and infections from the virus known as the Middle East respiratory syndrome, or MERS.           

TOPICS:

Actavis Global R&D President Leaving Company

April 21, 2014 9:54 am | News | Comments

Actavis has announced that G. Frederick Wilkinson, President, Actavis Global R&D, will leave the company effective April 25, 2014.  The company noted that Mr. Wilkinson has accepted the position of President and Chief Executive Officer at Impax Laboratories, Inc.

TOPICS:
Advertisement

Brewers Fear Proposed FDA Rule Would Spike Costs

April 21, 2014 8:55 am | News | Comments

Northwest beer brewers have joined a national outcry over a proposed rule from the Food and Drug Administration which they say would make it prohibitively expensive for them to recycle spent grain by providing it to dairy farmers.    

TOPICS:

Goggles See Cancer

April 21, 2014 8:50 am | Videos | Comments

A doctor created goggles that help surgeons detect cancer cells injected with dye.                            

Aastrom to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business

April 21, 2014 8:41 am | News | Comments

Aastrom Biosciences announced that it has entered into a definitive agreement to acquire Sanofi's Cell Therapy and Regenerative Medicine (CTRM) business for a purchase price of $6.5 million.                       

TOPICS:

Health Care Site Flagged in Heartbleed Review

April 21, 2014 8:30 am | by JULIE PACE, AP White House Correspondent | News | Comments

People who have accounts on the enrollment website for President Barack Obama's signature health care law are being told to change their passwords following an administration-wide review of the government's vulnerability to the confounding Heartbleed Internet security flaw.

TOPICS:

Saudi Arabia Reports Three More Deaths from MERS Virus

April 21, 2014 8:24 am | News | Comments

Saudi Arabia's health ministry says three more patients who contracted a potentially fatal Middle East virus related to SARS have died amid a recent increase in infections.             

TOPICS:

Second Wave of Milder Flu Hitting Northeast

April 21, 2014 8:17 am | by MIKE STOBBE, AP Medical Writer | News | Comments

A second, milder wave of flu is hitting the Northeast. Months ago, the flu season seemed to be winding down. But health officials on Friday reported widespread flu-like illnesses in six states.          

TOPICS:

Kids Get Codeine in ER Despite Risks, Guidelines

April 21, 2014 8:14 am | by LINDSEY TANNER, AP Medical Writer | News | Comments

Despite recommended limits on codeine use in children, the potent painkiller is prescribed for children in at least half a million emergency room visits each year, a study suggests.             

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading